Investigator Initiated Research

In addition to sponsoring its own research and research collaborations, Lilly has programs for considering external requests for Lilly provision of study drug and/or financial support for Investigator Initiated Research that is initiated, designed and sponsored by external researchers. Lilly considers such requests for support of Investigator Initiated Research projects based on scientific merit and strategic fit with Lilly’s areas of research interest. These reviews are carried out by global committees comprised of Lilly medical and scientific staff members from relevant therapeutic areas.

This site is intended for Health Care and Research Professionals over the age of 18.

For submissions related to Loxo Oncology at Lilly assets, please submit via Loxo Oncology at Lilly

The Concept to Trial Process

Concept

A simple description of the study idea in 1,000 characters or less. If in scope, the concept will move to the proposal stage.
Proposal

Once deemed in scope, submit a proposal with more details about the proposed research.
Protocol

For clinical studies, provide all study details.
Study Readiness

Activities such as contracting, budgeting, ethics review, and drug shipping.
Active Trial

The study is executed according to the protocol and contract.

Submit a Concept

After submitting your initial concept in the form below,
Lilly will review the concept and get back to you within 10 business days.

First Name

Middle Initial

Last Name

If you do not see your country listed, please select “Other” as your country and designate your country below in the Summary Description

Primary Organization Name

Secondary Organization Name

Phone

Contact Email

Choose Research Category

Clinical Request Non Clinical Request Diagnostic Research Translational Research

Research involving human subjects with marketed product(s) and/or investigational agent(s) per applicable regulatory guidelines Research in in-vitro, animal or human derived bio specimens or in-vivo animal models with marketed product(s) and/or investigational agent(s) per applicable regulatory guidelines Research of diagnosis of disease or other conditions, including a determination of the state of health. Research involving human subjects that aims to characterize disease processes, to generate novel biological hypotheses, or to identify biomarkers of response/resistance to a marketed product or investigational agent.

Select Therapeutic Area *

Oncology Diabetes Immunology Neurodegenerative Diseases Headache & Pain

Other Tumors *

If you do not see your compound listed, please select “Other” as your compound and indicate the compound in the Summary Description

Concept Title

Indication

Summary Description

By completing this form and clicking submit, you agree to the Privacy Statement linked to this site and are consenting to have your e-mail address and personal information you have provided to be collected and used by Eli Lilly and Company and its affiliates and representatives for processing your request for Investigator Initiated Research. Your information will be retained within a secure environment at Lilly.

Your Session will expire in 15 minutes. Click on Ok button to extend the session or Logout button to redirect to Login Page.

Investigator Initiated Research

The Concept to Trial Process

Concept

Proposal

Protocol

Study Readiness

Active Trial

Submit a Concept

Thank You!

Do you attest that the information contained in this submission is not confidential information?